S
South Shore Neurologic Associates, P.C. | Patchogue, NY
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
BIIB091
Aducanumab
BIIB080
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
The primary objectives are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis (RMS)...
Enrolling
Relapsing Forms of Multiple Sclerosis
Drug: BIIB091
Drug: DRF
In this study, researchers will learn more about a study drug called BIIB080. The study will focus on participants with mild cognitive impairment or...
Enrolling
Mild Cognitive Impairment Due to Alzheimer's Disease
Alzheimer's Disease Dementia
Drug: BIIB080-matching placebo
Drug: BIIB080
The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment a...
Active, not recruiting
Alzheimer's Disease
Drug: Placebo
Drug: Aducanumab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems